EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and prototyping exploration of an end effector for automated drug compounding

Lorenzo Giunta, Vimal Dhokia

Proceedings of the Design Society · 2026-08 · 6 · 3287-3296

DOI: 10.1017/pds.2026.10686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the Design Society, online erschienen am 02.07.2026. Verfasst von Lorenzo Giunta und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy (CTX) is essential for cancer treatment, yet its cytotoxic properties pose significant risks to clinicians. As cancer incidence rises, demand for safe and reliable CTX preparation methods intensifies; Automated Drug Compounding (ADC) promises to address these issues. Nonetheless, technical and operational barriers limit adoption. Foremost, the reliable manipulation of syringes by robotic end effectors remains a challenge. This paper examines limitations of current end effectors for ADC systems, identifies design requirements necessary, and proposes a novel design to address them.

Zitieren

APA

Giunta, L., & Dhokia, V. (2026). Design and prototyping exploration of an end effector for automated drug compounding. Proceedings of the Design Society, 6, 3287-3296. https://doi.org/10.1017/pds.2026.10686

Vancouver

Giunta L, Dhokia V. Design and prototyping exploration of an end effector for automated drug compounding. Proceedings of the Design Society. 2026;6:3287-3296. doi:10.1017/pds.2026.10686

BibTeX
@article{Giunta2026,
  author = {Giunta, Lorenzo and Dhokia, Vimal},
  title = {Design and prototyping exploration of an end effector for automated drug compounding},
  journal = {Proceedings of the Design Society},
  year = {2026},
  volume = {6},
  pages = {3287--3296},
  doi = {10.1017/pds.2026.10686}
}
Kostenlos starten →